Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Dietary supplements and medications in elite sport – polypharmacy or real need
Scandinavian Journal of Medicine and Science in Sports, 11/10/09
Lazic JS et al. – The study showed widespread use of DS and drugs by elite athletes. Consumption of DS with no evident performance or health benefits, demonstrated the need for specific educational programs focused on DS use. Amount, quantity and combination of the reported products raised concern about the risk of potential side effects.
Related Articles
Polypharmacy and Its Correlates in Village Health Clinics across 10 Provinces of Western China
Journal of Epidemiology and Community Health, 11/11/09
Relevance Score: 85%
A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy
Journal of Psychiatry & Neuroscience, 11/11/09
Relevance Score: 84%
Polypharmacy and Perioperative Medications in the Elderly
Anesthesiology Clinics, 10/16/09
Relevance Score: 82%
Epilepsy in later life
The Lancet Neurology, 10/19/09
Relevance Score: 80%
Acute kidney injury in the elderly: pathogenesis, diagnosis and therapy
Aging Health, 10/14/09
Relevance Score: 80%
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Gene-gene interactions in folate and adenosine biosynthesis pathways affect methotrexate efficacy and tolerability in rheumatoid arthritis
Pharmacogenetics and genomics, 11/23/09
Antiretroviral and Immunosuppressive Drug-Drug Interactions in Human Immunodeficiency Virus-Infected Liver and Kidney Transplant Recipients
Transplantation Proceedings, 11/20/09
If the KI is defined by the free energy of binding to P-gp, what kinetic parameters define the IC50 for the MDCKII-hMDR1 confluent cell monolayer
Drug Metabolism and Disposition, 11/20/09
Sponsor
Article Search
Sponsor


See Latest Articles


